Serine peptidase inhibitor Kazal type 2 gene expression level in de novo acute myeloid leukemia patients.

Saved in:
Bibliographic Details
Title: Serine peptidase inhibitor Kazal type 2 gene expression level in de novo acute myeloid leukemia patients.
Authors: Nawar, Sarah M.1 (AUTHOR) sarahmedhatnawar@gmail.com, Mahmoud, Asmaa2 (AUTHOR)
Source: Egyptian Journal of Haematology. Apr-Jun2025, Vol. 50 Issue 2, p435-440. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11101067
DOI:10.4103/ejh.ejh_16_25